Main > NEUROLOGY. > Parkinsons Disease > L-DOPA Induced DysKinesia > Treatment > Alpha2 Adrenergic Receptor > Antagonists > Fipamezole
Fipamezole's subsections
Clinical Study: Phase II (04.2003)
Development By:
FDA Status: Fast Track (11.2002)
Non-Patent Literature
Production (Contract Mfg.) By:
Fipamezole's products
This section has no products